CD4 and neoplasm: On the other hand, tumor antigen-specific CD4+ T cells have been demonstrated to represent essential contributors of CTL-mediated tumor attack [12], implying that epitopes presented by MHC II molecules to CD4+ T cells are of central importance in tumor immune surveillance [13].